What's in Pharmacosmos A/S's pipeline?

Pharmacosmos A/S has 4 drugs in our index: 2 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Pharmacosmos A/S's portfolio?

Top competitors by shared drug class: AMAG Pharmaceuticals, Inc., Medical University of Vienna, NICHD Global Network for Women's and Children's Health, Nicoletta C Machin, Oregon Health and Science University.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/pharmacosmos-a-s.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-14 · How we verify

Pharmacosmos A/S — Portfolio Competitive Intelligence Brief

Pharmacosmos A/S pipeline: 2 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
ferrous fumarate with ascorbic acid	ferrous fumarate with ascorbic acid	marketed	Iron supplement with vitamin C enhancer		Hematology
Monofer	Monofer	marketed			Other
Iron isomaltoside/ferric derisomaltose	Iron isomaltoside/ferric derisomaltose	phase 3	Iron replacement therapy	Iron metabolism pathway; ferric iron (Fe3+)	Hematology
Iron oligosaccharide	Iron oligosaccharide	phase 3	Iron supplement / Iron replacement therapy	Iron (Fe2+/Fe3+) absorption pathway	Hematology

Therapeutic area mix

Hematology · 3
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AMAG Pharmaceuticals, Inc. · 1 shared drug class
Medical University of Vienna · 1 shared drug class
NICHD Global Network for Women's and Children's Health · 1 shared drug class
Nicoletta C Machin · 1 shared drug class
Oregon Health and Science University · 1 shared drug class
Rambam Health Care Campus · 1 shared drug class
Services Institute of Medical Sciences, Pakistan · 1 shared drug class
Sumitomo Pharma America, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Pharmacosmos A/S:

Cite this brief

Drug Landscape (2026). Pharmacosmos A/S — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/pharmacosmos-a-s. Accessed 2026-05-14.